CTCs for High Grade Glioma

Clinical trial NCT02558335 · COMPLETED

Trial details

NCT number: NCT02558335
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Study type: OBSERVATIONAL

Stage III and IV Glioma Patients

Start date: 2013-04-01
Primary completion: 2017-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.